Initiates Coverage on Milestone Scientific (NYSE:MLSS)

Equities research analysts at assumed coverage on shares of Milestone Scientific (NYSE:MLSSGet Rating) in a report issued on Wednesday. The brokerage set a “sell” rating on the stock.

NYSE:MLSS opened at $0.95 on Wednesday. Milestone Scientific has a 1-year low of $0.75 and a 1-year high of $3.00. The firm has a 50-day moving average of $0.97. The firm has a market capitalization of $65.01 million, a price-to-earnings ratio of -7.92 and a beta of 1.45.

Milestone Scientific (NYSE:MLSSGet Rating) last released its earnings results on Tuesday, May 17th. The company reported ($0.03) earnings per share for the quarter. Milestone Scientific had a negative net margin of 76.86% and a negative return on equity of 47.99%. The company had revenue of $2.70 million during the quarter.

Milestone Scientific Company Profile (Get Rating)

Milestone Scientific Inc designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates in two segments, Dental and Medical. Its products include CompuDent and STA Single Tooth Anesthesia System that are used for all dental procedures that require local anesthetic.

Featured Stories

Receive News & Ratings for Milestone Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Milestone Scientific and related companies with's FREE daily email newsletter.